Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good morning. My name is Alan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx ...
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...
The Brighterside of News on MSN1d
Natural dietary supplement can successfully treat Alzheimer's diseaseA groundbreaking study by researchers from the University of Delaware College of Health Sciences and the National Institute ...
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...
Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...
The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting ...
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
Neurologist Dona Murphey, the founder of website PrognosUs, hopes her platform can give caregivers a place to find support in ...
Researchers are uncovering deeper insights into how the human brain ages and what factors may be tied to healthier cognitive ...
The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback